Showing 1 - 6 results of 6 for search 'Kathryn A. Bowman', query time: 0.04s Refine Results
  1. 1
    Understanding Fc function for rational vaccine design against pathogens

    Understanding Fc function for rational vaccine design against pathogens by Kathryn A. Bowman, Paulina Kaplonek, Ryan P. McNamara

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis

    Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from -responsive Lyme arthritis by Kathryn A. Bowman, Christine D. Wiggins, Elizabeth DeRiso, Steffan Paul, Klemen Strle, John A. Branda, Allen C. Steere, Douglas A. Lauffenburger, Galit Alter

    Published 2024-02-01
    Get full text
    Article
  3. 3
    Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 countsResearch in context

    Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 countsResearch in context by Maphe Mthembu, Kathryn A. Bowman, Leela R.L. Davies, Sharon Khuzwayo, Lusanda Mazibuko, Thierry Bassett, Dirhona Ramjit, Zoey Mhlane, Farina Karim, Galit Alter, Thumbi Ndung'u, Emily B. Wong

    Published 2023-04-01
    Get full text
    Article
  4. 4
    Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity

    Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity by Kathryn A. Bowman, Daniel Stein, Sally Shin, Kathie G. Ferbas, Nicole H. Tobin, Colin Mann, Stephanie Fischinger, Erica Ollmann Saphire, Douglas Lauffenburger, Anne W. Rimoin, Grace Aldrovandi, Galit Alter

    Published 2022-10-01
    Get full text
    Article
  5. 5
    The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia

    The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia by Chuangqi Wang, Yijia Li, Paulina Kaplonek, Matteo Gentili, Stephanie Fischinger, Kathryn A. Bowman, Moshe Sade-Feldman, Kyle R. Kays, James Regan, James P. Flynn, Marcia B. Goldberg, Nir Hacohen, Michael R. Filbin, Douglas A. Lauffenburger, Galit Alter, Jonathan Z. Li

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination

    Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination by Matthew J. Gorman, Nita Patel, Mimi Guebre-Xabier, Alex L. Zhu, Caroline Atyeo, Krista M. Pullen, Carolin Loos, Yenny Goez-Gazi, Ricardo Carrion, Jr., Jing-Hui Tian, Dansu Yuan, Kathryn A. Bowman, Bin Zhou, Sonia Maciejewski, Marisa E. McGrath, James Logue, Matthew B. Frieman, David Montefiori, Colin Mann, Sharon Schendel, Fatima Amanat, Florian Krammer, Erica Ollmann Saphire, Douglas A. Lauffenburger, Ann M. Greene, Alyse D. Portnoff, Michael J. Massare, Larry Ellingsworth, Gregory Glenn, Gale Smith, Galit Alter

    Published 2021-09-01
    Get full text
    Article

Search Tools: